Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE2
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
- Status
- RECRUITING
- Phase
- N/A
Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
- Status
- COMPLETED
- Phase
- NA
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
- Status
- COMPLETED
- Phase
- N/A
Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of RK0202 in Oral Mucositis
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck
- Status
- TERMINATED
- Phase
- PHASE2
Effects of Swallowing Therapy in Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- NA
A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET
- Status
- COMPLETED
- Phase
- N/A
Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas
- Status
- TERMINATED
- Phase
- PHASE2